Abstract
HTA210 Characteristics and Outcomes of Health Technology Assessment Submissions for Advanced Therapy Medicinal Products in Europe: Perspective From Non-EU5 Countries
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have